OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
26828055

Miwon Specialty Chemical Co Ltd

Specialty ChemicalsVerified

Miwon maintains a strong liquidity position with KRW 58.96 billion in cash and equivalents and a current ratio of 4.86, indicating robust short-term financial health. The company's debt-to-equity ratio of 0.08 suggests a conservative capital structure with minimal leverage. Free cash flow of KRW 28.49 billion and operating cash flow of KRW 76.52 billion support ongoing operations and potential reinvestment. Profitability metrics show a return on equity of 13.67% and return on assets of 11.16%, both exceeding the typical thresholds for the specialty chemicals industry. Operating income of KRW 65.48 billion and net income of KRW 61.30 billion reflect strong earnings performance relative to revenue of KRW 532.12 billion. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financial data. This concentration may expose the company to sector-specific risks, though the specialty chemicals industry is generally less cyclical than commodity chemicals. Miwon's growth trajectory is supported by consistent operating cash flow and a low debt burden, which allows for flexibility in capital allocation. The company's capital expenditure of KRW -45.12 billion indicates a focus on cost optimization rather than expansion in the most recent period. Risk factors are minimal, with low liquidity and dilution risk scores. No immediate filing-based liquidity or dilution flags were detected, and the company has not disclosed any dilutive events in recent filings. The absence of dilution pressure and strong cash position reduce near-term financial risk. Recent financial filings and transcripts do not indicate any material events or strategic shifts in the past 12 months. The company's financial performance remains stable, with no significant changes in operating or capital structure.

30-day price · 268280(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyMiwon Specialty Chemical Co Ltd
Ticker268280.KS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Miwon Specialty Chemical Co Ltd is a specialty chemicals company that produces and sells chemical products for industrial and consumer applications.

Classification. Miwon is classified in the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 92% confidence.

Miwon maintains a strong liquidity position with KRW 58.96 billion in cash and equivalents and a current ratio of 4.86, indicating robust short-term financial health. The company's debt-to-equity ratio of 0.08 suggests a conservative capital structure with minimal leverage. Free cash flow of KRW 28.49 billion and operating cash flow of KRW 76.52 billion support ongoing operations and potential reinvestment. Profitability metrics show a return on equity of 13.67% and return on assets of 11.16%, both exceeding the typical thresholds for the specialty chemicals industry. Operating income of KRW 65.48 billion and net income of KRW 61.30 billion reflect strong earnings performance relative to revenue of KRW 532.12 billion. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financial data. This concentration may expose the company to sector-specific risks, though the specialty chemicals industry is generally less cyclical than commodity chemicals. Miwon's growth trajectory is supported by consistent operating cash flow and a low debt burden, which allows for flexibility in capital allocation. The company's capital expenditure of KRW -45.12 billion indicates a focus on cost optimization rather than expansion in the most recent period. Risk factors are minimal, with low liquidity and dilution risk scores. No immediate filing-based liquidity or dilution flags were detected, and the company has not disclosed any dilutive events in recent filings. The absence of dilution pressure and strong cash position reduce near-term financial risk. Recent financial filings and transcripts do not indicate any material events or strategic shifts in the past 12 months. The company's financial performance remains stable, with no significant changes in operating or capital structure.
Key takeaways
  • Miwon has a strong liquidity position with a current ratio of 4.86 and KRW 58.96 billion in cash and equivalents.
  • The company's return on equity of 13.67% and return on assets of 11.16% indicate strong profitability.
  • Miwon's capital structure is conservative, with a debt-to-equity ratio of 0.08 and no immediate dilution risk.
  • Revenue is concentrated in a single business segment, which may increase exposure to sector-specific risks.
  • The company's capital expenditure of KRW -45.12 billion suggests a focus on cost optimization rather than expansion.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$532.12B
Gross profit$113.02B
Operating income$65.48B
Net income$61.30B
R&D
SG&A
D&A
SBC
Operating cash flow$76.52B
CapEx-$45.12B
Free cash flow$28.49B
Total assets$549.24B
Total liabilities$100.74B
Total equity$448.50B
Cash & equivalents$58.96B
Long-term debt$35.54B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$532.12B$65.48B$61.30B$28.49B
FY-1$509.27B$58.77B$54.57B$51.18B
FY-2$437.67B$22.53B$18.60B$10.99B
FY-3$611.65B$80.85B$64.82B$22.99B
FY-4$531.34B$95.03B$79.90B$41.46B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$549.24B$448.50B$58.96B
FY-1$512.10B$406.34B$68.62B
FY-2$461.19B$373.06B$99.33B
FY-3$475.73B$378.86B$42.05B
FY-4$438.13B$326.52B$60.54B
PeriodOCFCapExFCFSBC
FY0$76.52B-$45.12B$28.49B
FY-1$53.96B-$19.73B$51.18B
FY-2$109.52B-$25.35B$10.99B
FY-3$39.43B-$50.58B$22.99B
FY-4$32.44B-$45.61B$41.46B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$141.27B$19.28B$21.52B$14.96B
FQ-1$126.13B$10.10B$15.23B$1.18B
FQ-2$133.32B$18.19B$17.77B$9.98B
FQ-3$134.81B$19.21B$11.90B$8.20B
FQ-4$137.87B$17.99B$16.40B$17.89B
FQ-5$126.42B$13.19B$13.64B$12.72B
FQ-6$128.58B$16.27B$12.11B$12.58B
FQ-7$129.81B$16.74B$15.09B$7.87B
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$591.82B$459.03B$64.99B
FQ-1$549.24B$448.50B$58.96B
FQ-2$540.72B$433.98B$71.11B
FQ-3$523.61B$421.66B$64.57B
FQ-4$535.85B$411.17B$73.55B
FQ-5$512.10B$406.34B$68.62B
FQ-6$493.69B$397.62B$62.56B
FQ-7$488.09B$389.95B$116.22B
PeriodOCFCapExFCFSBC
FQ0$25.46B-$12.71B$14.96B
FQ-1$76.52B-$45.12B$1.18B
FQ-2$59.68B-$24.82B$9.98B
FQ-3$33.98B-$15.51B$8.20B
FQ-4$13.09B-$5.48B$17.89B
FQ-5$53.96B-$19.73B$12.72B
FQ-6$40.95B-$11.86B$12.58B
FQ-7$36.84B-$8.78B$7.87B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$448.50B
Net cash$23.42B
Current ratio4.9
Debt/Equity0.1
ROA11.2%
ROE13.7%
Cash conversion1.2%
CapEx/Revenue-8.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric268280Activity
Op margin12.3%0.4% medp25 -8.0% · p75 16.0%above median
Net margin11.5%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin21.2%20.8% medp25 14.9% · p75 24.0%above median
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-8.5%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity8.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-19 02:03 UTCJob: 33682b95